Related Experiment Videos
Plasma 3-0-methyldopa in L-dopa therapy of Parkinson's disease
Mayo Clinic Proceedings
|June 1, 1972
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
L-DOPA biotransformation: correlations of dosage, erythrocyte catechol O-methyltransferase and platelet SULT1A3 activities with metabolic pathways in Parkinsonian patients.
Journal of neural transmission (Vienna, Austria : 1996)·2003
Neuropathology of two members of a German-American kindred (Family C) with late onset parkinsonism.
Acta neuropathologica·2002
Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature.
Movement disorders : official journal of the Movement Disorder Society·2001
Intrarenal serotonin, dopamine, and phosphate handling in remnant kidneys.
Kidney international·2001
Motor unit changes in sporadic idiopathic Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society·2000
Incidence and Risk Factors for Severe Postoperative Hypotension in General Care Wards.
Mayo Clinic proceedings·2026
Primary Care Management of Ileal Pouch Disorders: Diagnosis, Treatment, and Referral.
Mayo Clinic proceedings·2026
Barriers and Facilitators to Innovation: A Qualitative Study in a Non-Profit Health Care System.
Mayo Clinic proceedings·2026
Zephyr, Vega, Milo, and Bell: "Living" Art at Mayo: The Mayo Clinic Peregrine Falcon Program.
Mayo Clinic proceedings·2026
From discovery to clinic: Medicinal chemistry strategies for PROTAC linker optimization.
European journal of medicinal chemistry·2026
From Reflection to Implementation: Tailored Clinical Development of a Pembrolizumab Biosimilar Candidate.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Performance of large language models on narrow therapeutic index drug monitoring: Implications for clinical pharmacy practice.
Journal of the American Pharmacists Association : JAPhA·2026
Solid Modification Strategies for Active Pharmaceutical Ingredients (APIs): A Systematic Review on Approaches, Improvements, and Limitations.
Pharmaceutical development and technology·2026
A comparative QbD-driven optimization of solid lipid nanoparticles and nanostructured lipid carriers for enhanced drug delivery.
Biochemical and biophysical research communications·2026